235 related articles for article (PubMed ID: 11605166)
1. Principles and problems of transfusion in sickle cell disease.
Telen MJ
Semin Hematol; 2001 Oct; 38(4):315-23. PubMed ID: 11605166
[TBL] [Abstract][Full Text] [Related]
2. Delayed hemolytic transfusion reaction/hyperhemolysis syndrome in children with sickle cell disease.
Talano JA; Hillery CA; Gottschall JL; Baylerian DM; Scott JP
Pediatrics; 2003 Jun; 111(6 Pt 1):e661-5. PubMed ID: 12777582
[TBL] [Abstract][Full Text] [Related]
3. Clinical presentation of delayed hemolytic transfusion reactions and hyperhemolysis in sickle cell disease.
Fasano RM; Miller MJ; Chonat S; Stowell SR
Transfus Clin Biol; 2019 May; 26(2):94-98. PubMed ID: 30837199
[TBL] [Abstract][Full Text] [Related]
4. Red blood cell alloimmunization and delayed hemolytic transfusion reactions in patients with sickle cell disease.
Balbuena-Merle R; Hendrickson JE
Transfus Clin Biol; 2019 May; 26(2):112-115. PubMed ID: 30857806
[TBL] [Abstract][Full Text] [Related]
5. Alloimmunization and hyperhemolysis in sickle cell disease.
Pirenne F; Pondarré C
Hematology Am Soc Hematol Educ Program; 2023 Dec; 2023(1):653-659. PubMed ID: 38066873
[TBL] [Abstract][Full Text] [Related]
6. Clinical significance of RBC alloantibodies and autoantibodies in sickle cell patients who received transfusions.
Aygun B; Padmanabhan S; Paley C; Chandrasekaran V
Transfusion; 2002 Jan; 42(1):37-43. PubMed ID: 11896310
[TBL] [Abstract][Full Text] [Related]
7. Anti-HI can cause a severe delayed hemolytic transfusion reaction with hyperhemolysis in sickle cell disease patients.
Ibanez C; Habibi A; Mekontso-Dessap A; Chadebech P; Chami B; Bierling P; Galactéros F; Rieux C; Nataf J; Bartolucci P; Peyrard T; Pirenne F
Transfusion; 2016 Jul; 56(7):1828-33. PubMed ID: 27145018
[TBL] [Abstract][Full Text] [Related]
8. Managing pregnancy in patients with sickle cell disease from a transfusion perspective.
Habibi A; Benachi A; Lecarpentier E
Hematology Am Soc Hematol Educ Program; 2023 Dec; 2023(1):640-645. PubMed ID: 38066847
[TBL] [Abstract][Full Text] [Related]
9. Hemolytic transfusion reaction after preoperative prophylactic blood transfusion for sickle cell disease in pregnancy.
Proudfit CL; Atta E; Doyle NM
Obstet Gynecol; 2007 Aug; 110(2 Pt 2):471-4. PubMed ID: 17666632
[TBL] [Abstract][Full Text] [Related]
10. Impact of Red Blood Cell Antigen Matching on Alloimmunization and Transfusion Complications in Patients with Sickle Cell Disease: A Systematic Review.
Fasano RM; Meyer EK; Branscomb J; White MS; Gibson RW; Eckman JR
Transfus Med Rev; 2019 Jan; 33(1):12-23. PubMed ID: 30122266
[TBL] [Abstract][Full Text] [Related]
11. [Blood transfusion assessment to 112 homozygous sickle-cell disease patients in university hospital of Brazzaville].
Dokekias AE; Ossini LN; Tsiba FO; Malanda F; Koko I; De Montalembert M
Transfus Clin Biol; 2009; 16(5-6):464-70. PubMed ID: 19369104
[TBL] [Abstract][Full Text] [Related]
12. Euvolemic automated transfusion to treat severe anemia in sickle cell disease patients at risk of circulatory overload.
Mercure-Corriveau N; Crowe EP; Vozniak S; Feng X; Rai H; Van Denakker T; Zakieh A; Grabowski MK; Lanzkron S; Tobian AAR; Bloch EM
Transfusion; 2024 Jan; 64(1):124-131. PubMed ID: 38069526
[TBL] [Abstract][Full Text] [Related]
13. [Delayed hemolytic transfusion reaction in sicle cell disease patients: a new challenge for the Hemovigilance network].
Rieux C; De Meyer E; Boudjedir K
Transfus Clin Biol; 2015 Mar; 22(1):37-41. PubMed ID: 25441454
[TBL] [Abstract][Full Text] [Related]
14. Peripartum hyperhemolysis prophylaxis and management in sickle cell disease: A case report and narrative review.
Vasanthamohan L; Choo S; Marshall T; Symons YT; Matsui D; Eastabrook G; Solh Z
Transfusion; 2020 Oct; 60(10):2448-2455. PubMed ID: 32851670
[TBL] [Abstract][Full Text] [Related]
15. Multiple hemolytic transfusion reactions misinterpreted as severe vaso-occlusive crisis in a patient with sickle cell disease.
Dean CL; Maier CL; Roback JD; Stowell SR
Transfusion; 2019 Feb; 59(2):448-453. PubMed ID: 30412270
[TBL] [Abstract][Full Text] [Related]
16. How we treat delayed haemolytic transfusion reactions in patients with sickle cell disease.
Gardner K; Hoppe C; Mijovic A; Thein SL
Br J Haematol; 2015 Sep; 170(6):745-56. PubMed ID: 25967919
[TBL] [Abstract][Full Text] [Related]
17. Transfusion-transmitted malaria masquerading as sickle cell crisis with multisystem organ failure.
Maier CL; Gross PJ; Dean CL; Chonat S; Ip A; McLemore M; El Rassi F; Stowell SR; Josephson CD; Fasano RM
Transfusion; 2018 Jun; 58(6):1550-1554. PubMed ID: 29524230
[TBL] [Abstract][Full Text] [Related]
18. Transfusion management in sickle cell disease.
Wanko SO; Telen MJ
Hematol Oncol Clin North Am; 2005 Oct; 19(5):803-26, v-vi. PubMed ID: 16214645
[TBL] [Abstract][Full Text] [Related]
19. Extended phenotyping does not preclude the occurrence of delayed haemolytic transfusion reactions in sickle cell disease.
Gerritsma J; Bongaerts V; Eckhardt C; Heijboer H; Nur E; Biemond B; van der Schoot E; Fijnvandraat K;
Br J Haematol; 2022 Feb; 196(3):769-776. PubMed ID: 34632580
[TBL] [Abstract][Full Text] [Related]
20. Management of delayed hemolytic transfusion reaction in sickle cell disease: Prevention, diagnosis, treatment.
Pirenne F; Bartolucci P; Habibi A
Transfus Clin Biol; 2017 Sep; 24(3):227-231. PubMed ID: 28669521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
